Page last updated: 2024-11-05

lauryl acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Lauryl acetate is an ester with the formula CH3COO(CH2)11CH3. It is a colorless liquid with a fruity odor. It is a common ingredient in fragrances and cosmetics. Lauryl acetate is synthesized by the reaction of lauryl alcohol with acetic acid. It is an important component of many essential oils, such as coconut oil and palm oil. It has been studied for its potential anti-inflammatory and antimicrobial properties. It is also being investigated for its potential use as a biofuel.'

Cross-References

ID SourceID
PubMed CID8205
CHEMBL ID2228460
CHEBI ID165649
SCHEMBL ID159219
MeSH IDM0129313

Synonyms (56)

Synonym
einecs 203-995-1
dodecyl alcohol acetate
brn 1769711
nsc 67366
dodecanyl ethanoate
lauryl ethanoate
fema no. 2616
ai3-11595
dodecyl acetate
1-dodecanol acetate
n-dodecyl acetate
112-66-3
lauryl acetate
dodecanol acetate
acetate c-12
wln: 12ov1
dodecyl alcohol, acetate
n-dodecyl ethanoate
nsc67366
acetic acid, dodecyl ester
dodecan-1-yl acetate
nsc-67366
dodecanyl acetate
lauryl acetate, >=98%, fg
dodecyl acetate, 97%
NCIOPEN2_003287
acetic acid dodecyl ester
acetic acid lauryl ester
A0902
CHEBI:165649
unii-76j36ke44b
76j36ke44b ,
LMFA07010262
tox21_303459
NCGC00257295-01
cas-112-66-3
dtxsid7047641 ,
dtxcid5027641
FT-0627727
AKOS015894270
dodecylacetate
CHEMBL2228460
SCHEMBL159219
okimelanolure
lauryl acetate [fhfi]
mfcd00008973
J-002812
acetic acid n-dodecyl ester
fema 2616
acetate c12
Q18352160
E78215
A894551
AS-56690
CS-0185581
HY-W127343
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carboxylic esterAn ester of a carboxylic acid, R(1)C(=O)OR(2), where R(1) = H or organyl and R(2) = organyl.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen nuclear receptor alphaHomo sapiens (human)Potency15.48640.000229.305416,493.5996AID743075
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency0.48970.023723.228263.5986AID743222
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1081323Nematicidal activity against Bursaphelenchus xylophilus at 0.5 mg/ml measured after 48 hr under microscope2010Journal of agricultural and food chemistry, Feb-10, Volume: 58, Issue:3
Structure-activity relationship of aliphatic compounds for nematicidal activity against pine wood nematode (Bursaphelenchus xylophilus).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (12.50)18.7374
1990's0 (0.00)18.2507
2000's6 (37.50)29.6817
2010's7 (43.75)24.3611
2020's1 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.21 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.15 (4.65)
Search Engine Demand Index44.00 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]